Moreover, AAs demonstrate a higher prevalence of epidermal growth factor receptor (EGFR) mutations [6], and they are less susceptible to the alternative polyadenylation of mRNA transcripts in lung cancer compared to WAs [7]. The gene discussed is EGFR; the disease is lung cancer.